We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sensor Test Indicates Early Inflammation in Oral Cavity

By LabMedica International staff writers
Posted on 28 Aug 2017
Researchers have developed a novel rapid test using chewing gum and the tongue as a 24/7 detector, potentially providing a diagnostic device that could be used by nearly “anyone, anywhere, anytime”. More...
Their first such gum was successful in using saliva samples to identify patients with dental implants who had early-stage inflammation due to bacterial infection. Expanding this platform technology to other diseases could also provide more efficient screening of large populations.

Dental implants occasionally entail complications: in the years after receiving an implant 6-15% of patients develop an inflammatory response caused by bacteria, in the worst case destroying the soft tissue and bone around the implant. When the new test will be available (planned for in 2-3 years), patients would benefit from a simple, quick, and affordable method to assess whether they carry such bacteria.

The gum test was developed by a pharmaceutical research team at Julius-Maximilians-University Würzburg (JMU, Wurzburg, Germany) to provide early detection aimed at preventing serious complications. "Anyone can use this new diagnostic tool anywhere and anytime without any technical equipment," said Prof. Lorenz Meinel of JMU, who co-led the development with Dr. Jennifer Ritzer. Initial proof-of-principle studies using saliva of patients were conducted at Merli Dental Clinic in Rimini.

The scientific background: In the presence of inflammatory conditions, specific protein-degrading enzymes (matrix metalloproteinases) are activated in the mouth. While chewing the gum, these enzymes also rapidly break down the special ingredient in gum: peptide sensors consisting of a protease cleavable linker in between a bitter substance and a microparticle. When the peptide is cleaved, the bitter tasting substance is released and detected by the tongue. Patients can then visit their dentist who confirms the diagnosis and treats the disease.

Chewing gum rapid tests for other medical applications are presently under development. "We hope to be able to diagnose other diseases with our “anyone, anywhere, anytime” diagnostics to identify and address these diseases as early as possible," said Prof. Meinel.

The study, by Ritzer J et al, was published August 15, 2017, in the journal Nature Communications.

Related Links:
Julius-Maximilians-University Würzburg


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Portable Electronic Pipette
Mini 96
New
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
New
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The tool enables scientists to track real-time fluctuations in T cell function with unprecedented speed and precision (Photo courtesy of Shutterstock)

Luminescent Probe Measures Immune Cell Activity in Real Time

The human immune system plays a vital role in defending against disease, but its activity must be precisely monitored to ensure effective treatment in cancer therapy, autoimmune disorders, and organ transplants.... Read more

Industry

view channel
Image: The collaboration supports clinical validation and regulatory submissions of the new T1D 4-plex assay on Revvity’s GSP instrument (Photo courtesy of Revvity)

Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes

Type 1 diabetes (T1D) is a lifelong autoimmune condition in which the immune system destroys the pancreas’s insulin-producing beta cells, leading to dependence on insulin therapy. Early detection is critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.